期刊
LEUKEMIA
卷 21, 期 6, 页码 1141-1149出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.leu.2404676
关键词
endothelial cell; progenitor cell; angiogenesis; vasculogenesis
资金
- NCI NIH HHS [P30 CA82709] Funding Source: Medline
- NHLBI NIH HHS [R21 HL088885, P01 HL085036] Funding Source: Medline
- NINDS NIH HHS [P50 NS052606] Funding Source: Medline
Since 1997, postnatal vasculogenesis has been purported to be an important mechanism for neoangiogenesis via bone marrow (BM)-derived circulating endothelial progenitor cells (EPCs). Based on this paradigm, EPCs have been extensively studied as biomarkers to assess severity of cardiovascular disease and as a cell-based therapy for several human cardiovascular disorders. In the majority of studies to date, EPCs were identified and enumerated by two primary methodologies; EPCs were obtained and quantified following in vitro cell culture, or EPCs were identified and enumerated by flow cytometry. Both methods have proven controversial. This review will attempt to outline the definition of EPCs from some of the most widely cited published reports in an effort to provide a framework for understanding subsequent studies in this rapidly evolving field. We will focus this review on studies that used cell culture techniques to define EPCs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据